Literature DB >> 24292834

Arrestin-dependent activation of JNK family kinases.

Xuanzhi Zhan1, Seunghyi Kook, Eugenia V Gurevich, Vsevolod V Gurevich.   

Abstract

The activity of all mitogen-activated protein kinases (MAPKs) is stimulated via phosphorylation by upstream MAPK kinases (MAPKK), which are in their turn activated via phosphorylation by MAPKK kinases (MAPKKKs). The cells ensure the specificity of signaling in these cascades by employing a variety of scaffolding proteins that bind matching MAPKKKs, MAPKKs, and MAPKs. All four vertebrate arrestin subtypes bind JNK3, but only arrestin-3 serves as a scaffold, promoting JNK3 activation in intact cells. Arrestin-3-mediated JNK3 activation does not depend on arrestin-3 interaction with G protein-coupled receptors (GPCRs), as demonstrated by the ability of some arrestin mutants that cannot bind receptors to activate JNK3, whereas certain mutants with enhanced GPCR binding fail to promote JNK3 activation. Recent findings suggest that arrestin-3 directly binds both MAPKKs necessary for JNK activation and facilitates JNK3 phosphorylation at both Thr (by MKK4) and Tyr (by MKK7). JNK3 is expressed in a limited set of cell types, whereas JNK1 and JNK2 isoforms are as ubiquitous as arrestin-3. Recent study showed that arrestin-3 facilitates the activation of JNK1 and JNK2, scaffolding MKK4/7-JNK1/2/3 signaling complexes. In all cases, arrestin-3 acts by bringing the kinases together: JNK phosphorylation shows biphasic dependence on arrestin-3, being enhanced at lower and suppressed at supraoptimal concentrations. Thus, arrestin-3 regulates the activity of multiple JNK isoforms, suggesting that it might play a role in survival and apoptosis of all cell types.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24292834      PMCID: PMC4514028          DOI: 10.1007/978-3-642-41199-1_13

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  96 in total

Review 1.  G-protein-coupled receptors: turn-ons and turn-offs.

Authors:  C V Carman; J L Benovic
Journal:  Curr Opin Neurobiol       Date:  1998-06       Impact factor: 6.627

2.  The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms.

Authors:  V V Gurevich
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

3.  Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins.

Authors:  Sergey A Vishnivetskiy; Luis E Gimenez; Derek J Francis; Susan M Hanson; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

4.  A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.

Authors:  Sergio Coffa; Maya Breitman; Benjamin W Spiller; Vsevolod V Gurevich
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

Review 5.  Role of the JNK pathway in human diseases.

Authors:  Kanaga Sabapathy
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  The functional cycle of visual arrestins in photoreceptor cells.

Authors:  Vsevolod V Gurevich; Susan M Hanson; Xiufeng Song; Sergey A Vishnivetskiy; Eugenia V Gurevich
Journal:  Prog Retin Eye Res       Date:  2011-07-29       Impact factor: 21.198

7.  Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.

Authors:  Jungwon Seo; Elviche L Tsakem; Maya Breitman; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

8.  Manipulation of very few receptor discriminator residues greatly enhances receptor specificity of non-visual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Faiza Baameur; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

9.  Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.

Authors:  Maya Breitman; Seunghyi Kook; Luis E Gimenez; Britney N Lizama; Maria C Palazzo; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

Review 10.  Scaffold proteins: hubs for controlling the flow of cellular information.

Authors:  Matthew C Good; Jesse G Zalatan; Wendell A Lim
Journal:  Science       Date:  2011-05-06       Impact factor: 47.728

View more
  10 in total

Review 1.  G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.

Authors:  Pierre-Yves Jean-Charles; Suneet Kaur; Sudha K Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

2.  Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95.

Authors:  Clara Alice Musi; Giacomo Marchini; Arianna Giani; Giovanni Tomaselli; Erica Cecilia Priori; Luca Colnaghi; Tiziana Borsello
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

3.  A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling.

Authors:  Ya Zhuo; Vsevolod V Gurevich; Sergey A Vishnivetskiy; Candice S Klug; Adriano Marchese
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

4.  Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.

Authors:  Nicole A Perry; Tamer S Kaoud; Oscar O Ortega; Ali I Kaya; David J Marcus; John M Pleinis; Sandra Berndt; Qiuyan Chen; Xuanzhi Zhan; Kevin N Dalby; Carlos F Lopez; T M Iverson; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

5.  Regulation of N-Formyl Peptide Receptor Signaling and Trafficking by Arrestin-Src Kinase Interaction.

Authors:  Brant M Wagener; Nicole A Marjon; Eric R Prossnitz
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

Review 6.  Multifaceted role of β-arrestins in inflammation and disease.

Authors:  D Sharma; N Parameswaran
Journal:  Genes Immun       Date:  2015-09-17       Impact factor: 2.676

7.  Structural basis of arrestin-3 activation and signaling.

Authors:  Qiuyan Chen; Nicole A Perry; Sergey A Vishnivetskiy; Sandra Berndt; Nathaniel C Gilbert; Ya Zhuo; Prashant K Singh; Jonas Tholen; Melanie D Ohi; Eugenia V Gurevich; Chad A Brautigam; Candice S Klug; Vsevolod V Gurevich; T M Iverson
Journal:  Nat Commun       Date:  2017-11-10       Impact factor: 14.919

Review 8.  JNK and cardiometabolic dysfunction.

Authors:  Siobhan M Craige; Kai Chen; Robert M Blanton; John F Keaney; Shashi Kant
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

9.  Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.

Authors:  Nicole A Perry-Hauser; Tamer S Kaoud; Henriette Stoy; Xuanzhi Zhan; Qiuyan Chen; Kevin N Dalby; Tina M Iverson; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

10.  Functional competence of a partially engaged GPCR-β-arrestin complex.

Authors:  Punita Kumari; Ashish Srivastava; Ramanuj Banerjee; Eshan Ghosh; Pragya Gupta; Ravi Ranjan; Xin Chen; Bhagyashri Gupta; Charu Gupta; Deepika Jaiman; Arun K Shukla
Journal:  Nat Commun       Date:  2016-11-09       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.